609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation

0 avis

609TiPPRODIGE 50 - ASPIK French: French double blind randomised study of aspirin versus placebo in resected stage III or high risk stage II colon cancer with PIK3CA mutation

Archive ouverte

Edité par CCSD -

IF 11.855. International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Predictive factors for early progression during induction chemotherapy (IC) and chemotherapy-free interval (CFI): Analysis from PRODIGE 9 trial

Archive ouverte | Aparicio, T. | CCSD

IF 11.855 . International audience

PFOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases (RCSM): Final results of the FFCD 1102 phase II trial

Archive ouverte | Bachet, J-B. | CCSD

IF 11.855. International audience

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

Archive ouverte | Walter, T. | CCSD

IF 6.029. International audience. BackgroundDiagnosis and management of poorly differentiated gastro-entero-pancreatic (GEP) neuroendocrine carcinomas (NECs) remain challenging. Recent studies suggest prognostic het...

Chargement des enrichissements...